Skip to content
Search

Latest Stories

Pharmacists to get 'Acon Flowflex' new LFD test kits for Covid-19

Community pharmacy contractors ordering lateral flow device (LFD) test kits will receive a different brand of test kits (Acon Flowflex) from Alliance Healthcare, once the existing stock of the Innova test kits has been distributed.

"When the new stock is received, the Innova test kits should continue to be supplied to patients in the first instance to use up the pharmacy’s existing stock," the Pharmaceutical Services Negotiating Committee (PSNC) said.


A carton (outer) of the Acon FlowFlex test kits will contain 56 test kits and the carton dimensions are 36 x 38.5 x 44cm.

The main differences to note as well as the pack size, are that the Acon Flowflex test kits: are nasal swab only; and provide a test result within 15 minutes instead of 30 minutes – the test should not be left to develop for longer than 30 minutes as this will void the test and will need to be repeated.

It is therefore important for pharmacists to continue to advise patients to follow the instructions on how to use the tests kits contained within the box.

The changes in pack size will not affect the weekly reporting requirement for stock received as contractors are required to report the quantity of cartons (outers) received, not the number of test kits (as well as the lot number, supplying wholesale and date of receipt).

Contractors can continue to use the same PIP code (8943995) to order LFD tests for the time being. As new LFD products are introduced, if there is a subsequent change in the PIP code, PNSC will communicate this to contractors.

 

More For You

Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less